- Home
- GLSI vs AMPY Comparison
GLSI vs AMPY Comparison
Compare GLSI & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLSI
- AMPY
- Stock Information
- Founded
- GLSI 2006
- AMPY 2011
- Country
- GLSI United States
- AMPY United States
- Employees
- GLSI N/A
- AMPY N/A
- Industry
- GLSI Biotechnology: Pharmaceutical Preparations
- AMPY Oil & Gas Production
- Sector
- GLSI Health Care
- AMPY Energy
- Exchange
- GLSI Nasdaq
- AMPY Nasdaq
- Market Cap
- GLSI 134.6M
- AMPY 152.1M
- IPO Year
- GLSI 2020
- AMPY 2011
- Fundamental
- Price
- GLSI $11.75
- AMPY $3.69
- Analyst Decision
- GLSI Strong Buy
- AMPY Strong Buy
- Analyst Count
- GLSI 1
- AMPY 2
- Target Price
- GLSI $39.00
- AMPY $10.25
- AVG Volume (30 Days)
- GLSI 78.4K
- AMPY 796.6K
- Earning Date
- GLSI 08-13-2025
- AMPY 08-06-2025
- Dividend Yield
- GLSI N/A
- AMPY N/A
- EPS Growth
- GLSI N/A
- AMPY N/A
- EPS
- GLSI N/A
- AMPY 0.39
- Revenue
- GLSI N/A
- AMPY $290,431,100.00
- Revenue This Year
- GLSI N/A
- AMPY $1.19
- Revenue Next Year
- GLSI N/A
- AMPY N/A
- P/E Ratio
- GLSI N/A
- AMPY $9.34
- Revenue Growth
- GLSI N/A
- AMPY N/A
- 52 Week Low
- GLSI $8.06
- AMPY $2.27
- 52 Week High
- GLSI $16.50
- AMPY $7.76
- Technical
- Relative Strength Index (RSI)
- GLSI 53.88
- AMPY 54.55
- Support Level
- GLSI $11.16
- AMPY $3.54
- Resistance Level
- GLSI $11.73
- AMPY $4.01
- Average True Range (ATR)
- GLSI 0.74
- AMPY 0.21
- MACD
- GLSI -0.08
- AMPY 0.00
- Stochastic Oscillator
- GLSI 42.91
- AMPY 57.39
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.